Werewolf Therapeutics Inc. (HOWL) NASDAQ
$6.43 (0.01) (-0.15%)
Market Cap: $279.16M
As of 04/24/24 10:38 AM EDT. Market open.
Werewolf Therapeutics Inc. (HOWL)
NASDAQ
$6.43
(0.01) (-0.15%)
Market Cap: $279.16M
As of 04/24/24 10:38 AM EDT. Market open.
Add to Portfolio
we are an immuno-oncology company advancing a pipeline of next generation, transformative cancer ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
44
Address
.
PRICE CHART FOR WEREWOLF THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.57
Previous Close
$6.44
Days Range
$6.01 - $6.44
52 week range
$1.57 - $8.19
Volume
27,628
Avg. Volume (30 days)
203,956
Market Cap
$279.16M
Dividend Yield
-
P/E
(7.47)
Shares Outstanding
43,347,363
Open
$6.57
Previous Close
$6.44
Days Range
$6.01 - $6.44
52 week range
$1.57 - $8.19
Volume
27,628
Avg. Volume (30 days)
203,956
Market Cap
$279.16M
Dividend Yield
-
P/E
(7.47)
Shares Outstanding
43,347,363
FINANCIAL STATEMENTS FOR WEREWOLF THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR WEREWOLF THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jan 06, 2023 | Buy | $2.21 | 1,853,000 | 4,095,130 | 5,701,056 | Jan 10, 2023, 05:14 PM |
| Seidel-Dugan Cynthia | Chief Scientific Officer | Jan 12, 2022 | Option Exercise | $2.81 | 39,731 | 111,838 | 164,888 | Jan 14, 2022, 05:58 PM |
| Leonard Reid | Chief Operating Officer | Dec 15, 2021 | Sale | $13.41 | 3,000 | 40,242 | 122,292 | Dec 17, 2021, 04:17 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | May 04, 2021 | Buy | $16.00 | 1,715,000 | 27,440,000 | 3,524,758 | May 06, 2021, 04:31 PM |
| GADICKE ANSBERT | 10% Owner | May 04, 2021 | Buy | $16.00 | 245,000 | 3,920,000 | 6,672,183 | May 06, 2021, 04:19 PM |
| EVNIN LUKE | Director | May 04, 2021 | Buy | $16.00 | 150,799 | 2,412,784 | 4,284,172 | May 06, 2021, 04:19 PM |
| Asanuma Sakae | Director | May 04, 2021 | Buy | $16.00 | 312,500 | 5,000,000 | 2,068,909 | May 04, 2021, 04:31 PM |
| Sphera Global Healthcare Management LP | 10% Owner | May 04, 2021 | Buy | $16.00 | 475,000 | 7,600,000 | 787,997 | May 04, 2021, 01:21 PM |
| Flynn James E | 10% Owner | May 04, 2021 | Buy | $16.00 | 800,000 | 12,800,000 | 2,552,787 | May 04, 2021, 12:34 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| RA CAPITAL MANAGEMENT, L.P. | Director | 01/06/2023 | 4,095,130 |
| Seidel-Dugan Cynthia | Chief Scientific Officer | 01/12/2022 | 111,838 |
| Leonard Reid | Chief Operating Officer | 12/15/2021 | 40,242 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 05/04/2021 | 27,440,000 |
| GADICKE ANSBERT | 10% Owner | 05/04/2021 | 3,920,000 |
| EVNIN LUKE | Director | 05/04/2021 | 2,412,784 |
| Asanuma Sakae | Director | 05/04/2021 | 5,000,000 |
| Sphera Global Healthcare Management LP | 10% Owner | 05/04/2021 | 7,600,000 |
| Flynn James E | 10% Owner | 05/04/2021 | 12,800,000 |
FUNDS WITH A POSITION IN WEREWOLF THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 6,179,035 | 0.59% | 0.56% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,034,255 | 0.02% | 203.24% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 194,308 | 0.00008% | 11.51% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 107,506 | 0.00064% | 137.85% | Other |
| BLACKROCK INC. | 72,228 | 0.00001% | -6.33% | Other |
CHANGE IN SHARES OUTSTANDING FOR WEREWOLF THERAPEUTICS INC
STOCK BUYBACKS FOR WEREWOLF THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
2.60%
1Q
06/30/2023
2.88%
2Q
03/31/2023
5.16%
3Q
12/31/2022
18.94%
4Q
09/30/2022
22.90%
5Q
06/30/2022
32.94%
6Q
03/31/2022
33.54%
7Q
09/30/2021
34.55%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR WEREWOLF THERAPEUTICS INC
LOADING...